Literature DB >> 1345952

Coagulation-factor deficiencies and abnormal bleeding in Noonan's syndrome.

M Sharland1, M A Patton, S Talbot, A Chitolie, D H Bevan.   

Abstract

Noonan's syndrome is characterised by a dysmorphic facies, congenital heart disease, and short stature, and is inherited as an autosomal dominant trait. Because abnormal bleeding has also been reported, we investigated a group of patients for coagulation-factor deficits. Of the 72 individuals studied (37 male, 35 female, mean age 11.4 years), 47 (65%) had a history of abnormal bruising or bleeding. 29 patients (40%) had a prolonged activated partial thromboplastin time. Specific abnormalities in the intrinsic pathway of coagulation (partial factor XI:C, XII:C, and VIII:C deficiencies) were found in 36 patients (50%). Multiple abnormalities among these 36 patients included combined factor XI:C and XII:C deficiencies (4 patients) and factor XI:C and VIII:C deficiencies (4), and 1 patient had combined factor VIII:C, XI:C, and XII:C deficiency. There was poor correlation between a history of abnormal bleeding and coagulation-factor deficit. In five families, similar coagulation-factor deficiencies were present in first-degree relatives with the syndrome. The pattern of inherited bleeding abnormalities seen in Noonan's syndrome suggests autosomal regulation of the intrinsic coagulation pathway.

Entities:  

Mesh:

Year:  1992        PMID: 1345952     DOI: 10.1016/0140-6736(92)90141-o

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  18 in total

1.  Noonan syndrome: clinical aspects and molecular pathogenesis.

Authors:  M Tartaglia; G Zampino; B D Gelb
Journal:  Mol Syndromol       Date:  2010-01-15

Review 2.  CHD associated with syndromic diagnoses: peri-operative risk factors and early outcomes.

Authors:  Benjamin J Landis; David S Cooper; Robert B Hinton
Journal:  Cardiol Young       Date:  2015-09-08       Impact factor: 1.093

3.  When and why is surgical revascularization indicated for the treatment of moyamoya syndrome in patients with RASopathies? A systematic review of the literature and a single institute experience.

Authors:  Marcello Scala; Pietro Fiaschi; Valeria Capra; Maria Luisa Garrè; Domenico Tortora; Marcello Ravegnani; Marco Pavanello
Journal:  Childs Nerv Syst       Date:  2018-05-24       Impact factor: 1.475

4.  Regulation of the Small GTPase Ras and Its Relevance to Human Disease.

Authors:  Kayla R Kulhanek; Jeroen P Roose; Ignacio Rubio
Journal:  Methods Mol Biol       Date:  2021

Review 5.  The cardiofaciocutaneous syndrome.

Authors:  A Roberts; J Allanson; S K Jadico; M I Kavamura; J Noonan; J M Opitz; T Young; G Neri
Journal:  J Med Genet       Date:  2006-07-06       Impact factor: 6.318

6.  Factor XI and phosphorylase b kinase deficiency.

Authors:  B Sölder; C Pechlaner; W Sperl; D Skladal; F Kunz; Y S Shin
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

7.  The natural history of Noonan syndrome: a long-term follow-up study.

Authors:  A C Shaw; K Kalidas; A H Crosby; S Jeffery; M A Patton
Journal:  Arch Dis Child       Date:  2006-09-21       Impact factor: 3.791

8.  Noonan's and DiGeorge syndromes with monosomy 22q11.

Authors:  D I Wilson; S B Britton; C McKeown; D Kelly; I E Cross; S Strobel; P J Scambler
Journal:  Arch Dis Child       Date:  1993-02       Impact factor: 3.791

9.  Abdominal ultrasound in Noonan syndrome: a study of 44 patients.

Authors:  C D George; M A Patton; M el Sawi; M Sharland; E J Adam
Journal:  Pediatr Radiol       Date:  1993

10.  Genital tract function in men with Noonan syndrome.

Authors:  M M Elsawi; J P Pryor; G Klufio; C Barnes; M A Patton
Journal:  J Med Genet       Date:  1994-06       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.